(Total Views: 496)
Posted On: 06/21/2021 10:36:36 AM
Post# of 149219
If one could kindly tell me what is wrong with this post? Not sure what I said to get it deleted...the rules of the board have apparently changed in the 2 years I've been here. I voiced wanting to know more info because the PR today really didn't have a whole lot in it. Or is there machine learning turned on so that any mention of 13D is an auto delete?? No cussing, not condescending toward anyone. Just thinking questions out loud.
For reference: "I hope the CC sheds more light on some numbers because the press release really didn't have much meat in it. Improvement over placebo in 18 of 24 symptoms is good, but how much better? In how many of the patients? Percentages of patients improved would be nice, although the number is small so maybe it's a bit skewed, but if they said 70-90% of patients receiving leronlimab improved....that's a number to get excited about. So far I only know that some symptoms were better over placebo. Maybe they did that so more CC questions would be about the data and less about the 13D group...or they don't have it and still awaiting topline?"
For reference: "I hope the CC sheds more light on some numbers because the press release really didn't have much meat in it. Improvement over placebo in 18 of 24 symptoms is good, but how much better? In how many of the patients? Percentages of patients improved would be nice, although the number is small so maybe it's a bit skewed, but if they said 70-90% of patients receiving leronlimab improved....that's a number to get excited about. So far I only know that some symptoms were better over placebo. Maybe they did that so more CC questions would be about the data and less about the 13D group...or they don't have it and still awaiting topline?"
(8)
(0)Scroll down for more posts ▼
